JD
Joost De Brouwer
Account Director at Timeinvest
View Joost's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Account Director
Present
Company Details
11-50 Employees
In today's fast-paced business environment, effective meetings are crucial for success. However, studies reveal that meetings can often be a major drain on productivity, consuming over 15% of an organisation's total working time. As a manager or meeting owner, it is imperative to optimise these valuable moments to maximise outcomes. At TimeInvest, we understand the challenges posed by inefficient and unproductive meetings. Our mission is to revolutionize the way meetings are conducted, ensuring they become a catalyst for progress rather than a time sink. With our innovative tool, TimeInvest, we empower meeting owners to unlock the full potential of their teams by capturing anonymous, qualitative, and unbiased feedback. By giving every participant a voice, we enable transparent discussions and actionable insights that propel organizations forward. TimeInvest equips you with a user-friendly platform to effortlessly measure and improve meeting efficiency. Our solution empowers employees to evaluate their own time usage, as they are the best judges of their own contributions and needs. Say goodbye to wasted hours and demotivated employees. Experience the transformative power of TimeInvest and take control of your meetings like never before. Join us in shaping a future where every interaction counts, driving your organisation towards greater success. ⏱️Transforming Meetings: Boost Efficiency with Anonymous, Qualitative, and Unbiased Feedback
Year Founded
2023
Social Media
Linkedin
Industry
Information Technology & Services
HQ Location
TT. Vasumweg 58 Amsterdam, 1033 SC, NL
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Joost De Brouwer in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.